Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection

Conditions

• Melanoma
• Skin Cancer
• Cancer

Interventions

• DRUG: Temozolomide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

• [object Object]